US FDA grants breakthrough therapy designation to Synageva's s...Synageva BioPharma Corp. (Synageva) has announced that the US Food and Drug Administration (FDA) granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency (LAL deficiency), also ... PharmaBiz, 2 days ago |
1,107 images for us food and drug administration | ||||
Pivotal moment hit in battle over genetically enhanced foodThe decades-old fight over genetically modified food has reached a fever pitch in Washington. The Obama administration and Congress are weighing the safety of technological advances that seem ripped from science fiction, including salmon that can ... The Hill, 1 day ago
FMI, USDA and FDA Address Risk of Listeria Monocytogenes in Retail Delicatessens
GroceryHeadquarters.com, 22 hours ago
Assistance with U.S. FDA's Detention without Physical Examination
Food Safety Magazine, 1 day ago
FDA Says GMO Salmon Wont Harm Environment
Food Logistics, 1 day ago
More from: USAgNet, USAgNet...and 10 other sources
|
Daiichi may sue Ranbaxy ex-owners for hiding infoSmarting from its $500 million fine from the US Food and Drug Administration (FDA) last week, Japan's Daiichi Sankyo, the current promoter of Ranbaxy Laboratories, indicated on Wednesday that it might take legal recourse against the Indian generic ... Financial Chronicle, 23 hours ago
Daiichi may sue ex-Ranbaxy promoters for false info
Moneycontrol.com, 1 day ago
|
Wockhardt hit by FDA import alert on drug plant(Reuters) - The U.S. Food and Drug Administration imposed an "import alert" on a plant operated by generic drugmaker Wockhardt Ltd, sending its shares down 20 percent on Thursday to their lowest level in seven months. An "import alert", effectively a ban, ... Business Standard, 3 hours ago
|
Cartelisation of drugs to stop: FDAThe Maharashtra Food and Drug Administration (FDA) has decided to crack down on the cartelisation of the medicine and drug industry by asking companies to terminate their memorandums of understanding (MoU) in order to be able to manufacture drugs that are in ... Asian Age, 1 day ago
Hologic Inc Receives FDA Approval For New Low-dose 3D Mammography (Breast Tomosynthesis) Solution For Breast Cancer Screening
Reuters, 2 days ago
New Asthma Drug Excites Patients -- And Its Maker
Forbes.com, 2 days ago
Drug market niche buoys local biotech's bottom line
Business in Vancouver, 2 days ago
|
Biogen Idec submits application to FDA for approval of PLEGRIDY in multiple sclerosisToday Biogen Idec (NASDAQ: BIIB) announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable ... European Pharmaceutical Review, 1 day ago
BRIEF: Biogen Idec seeks FDA approval for new MS drug
Individual.com, 2 days ago
Biogen Idec seeks approval for fourth MS drug
New York Business Journal, 2 days ago
Biogen Idec Submits BLA to FDA for Approval of PLEGRIDY for Multiple Sclerosis
Benzinga.com, 2 days ago
More from: , Equities.com...and 3 other sources
|
US FDA issues draft guideline on expanded access to IND for treatment; expects industry views before July 1The US Food and Drug Administration (FDA) has now issued a draft guideline on expanded access to investigational new drugs (IND) for treatment use in a 21 questions and answers format. The regulatory authority is now seeking the responses on this by ... PharmaBiz, 3 days ago
|
Aurobindo gets US FDA nodAurobindo Pharma has received final approvals from the US Food and Drug Administration (US FDA) to manufacture and market tamsulosin hydrochloride capsules USP 0.4mg (ANDA 202433) and clindamycin palmitate hydrochloride for oral solution USP ... Express Pharma, 1 week ago
Aurobindo gets FDA nod for two drugs
DNA, 2 weeks ago
Aurobindo receives USFDA approval for two products
Business Standard, 2 weeks ago
SPARC dips as FDA rejects Levetiracetam NDA
Business Standard, 2 weeks ago
More from: , Money Control...and 5 other sources
|
UPDATE 1-U.S. FDA approves J&J's Simponi to treat ulcerative colitisMay 15 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon. Simponi is already approved to treat ... Reuters, 1 week ago
New diabetes drug flushes away sugar
Asian Age, 1 month ago
FDA Asks Bakery to Shut Shop After Finding Sugar in Supposedly Sugar-Free Snacks
Med India, 2 months ago
|
Intendis, Bayer sue Glenmark on generic FinaceaGlenmark Generics Limited has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) with a Paragraph IV Certification, to sell generic version of Azelaic Acid, gel 15% topical. Business Standard, 2 months ago
Glenmark Generics receives ANDA from US FDA
Express Pharma, 1 week ago
|